Vascular Aging Is Accelerated in Hematological Cancer Survivors Who Undergo Allogeneic Stem Cell Transplant.
Rachel E ClimieHayley T DillonYuki Horne-OkanoImogen WallaceSharon AveryBronwyn A KingwellAndre La GercheErin J HowdenPublished in: Hypertension (Dallas, Tex. : 1979) (2023)
This study provides evidence of an accelerated vascular aging phenotype in allogeneic SCT survivors and provides insight into the increased burden of cardiovascular disease among hematologic cancer survivors.